AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.06B
HNCAX
Price
$21.42
Change
+$0.04 (+0.19%)
Updated
Oct 17 closing price
Net Assets
368.15M
Interact to see
Advertisement

AEPCX vs HNCAX

Header iconAEPCX vs HNCAX Comparison
Open Charts AEPCX vs HNCAXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.06B
Hartford International Growth A
Price$21.42
Change+$0.04 (+0.19%)
VolumeN/A
Net Assets368.15M
AEPCX vs HNCAX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. HNCAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and HNCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. HNCAX (368M). AEPCX pays higher dividends than HNCAX: AEPCX (0.16) vs HNCAX (0.04). AEPCX was incepted earlier than HNCAX: AEPCX (25 years) vs HNCAX (24 years). AEPCX (1.57) is less costly to investors than HNCAX (1.33). AEPCX is a more actively managed with annual turnover of: 35.00 vs. HNCAX (31.00). AEPCX has a lower initial minimum investment than HNCAX: AEPCX (250) vs HNCAX (2000). HNCAX annual gain was more profitable for investors over the last year : 23.10 vs. AEPCX (10.02). HNCAX return over 5 years is better than : 28.51 vs. AEPCX (9.92).
AEPCXHNCAXAEPCX / HNCAX
Total Expense Ratio1.571.30121%
Annual Report Gross Expense Ratio1.571.33118%
Fund Existence25 years24 years-
Gain YTD20.63125.77880%
Front LoadN/A6%-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets137B368M37,228%
Annual Yield % from dividends0.160.04361%
Returns for 1 year10.0223.1043%
Returns for 3 years45.8583.6655%
Returns for 5 years9.9228.5135%
Returns for 10 years36.7680.8845%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp